Home LiteratureArticle Details
PMID: 11770905 Published · ppublish English Journal Article Review

Tissue microarrays: applications in neuropathology research, diagnosis, and education.

Brain pathology (Zurich, Switzerland) ·Vol. 12 ·No. 1 ·2002-01-00 ·Pages 95-107

Wang H, Wang H, Zhang W, Fuller GN

Abstract

Tissue microarrays (TMAs) are composite paraffin blocks constructed by extracting cylindrical tissue core "biopsies" from different paraffin donor blocks and re-embedding these into a single recipient (microarray) block at defined array coordinates. Using this technique, up to 1000 or more tissue samples can be composited into a single paraffin block. Tissue microarrays permit high-volume simultaneous analysis of molecular targets at the DNA, mRNA, and protein levels under identical, standardized conditions on a single glass slide, and also provide maximal preservation and utilization of limited and irreplaceable archival tissue samples. This versatile technique facilitates retrospective and prospective human tissue studies, animal tissue studies, and cell line cytospin cell block studies. In this review, we present the technical aspects of TMA construction and sectioning, validation aspects of the technique, TMA advantages and limitations, and a sampling of the broad range of TMA uses in modern neuropathologic clinical diagnosis, research, and education. A specific illustration of the most widely employed and increasingly important TMA application is also presented: confirmation via TMA-based immunohistochemistry of the differential expression of a marker (IGFBP2) initially identified by gene expression profiling to be overexpressed in glioblastoma.

MeSH Terms
Animals Biomarkers, Tumor Central Nervous System Diseases/pathology Histocytochemistry/instrumentation,methods Humans Microtomy/instrumentation,methods Paraffin Embedding/instrumentation,methods Staining and Labeling/instrumentation,methods
Chemicals
Biomarkers, Tumor
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Wang Huamin
Department of Pathology and Laboratory Medicine, The University of Texas Medical School at Houston, USA.
Wang Hua
Zhang Wei
Fuller Gregory N
References (29)
29 references, click to expand
  1. High topoisomerase IIalpha expression associates with high proliferation rate and and poor prognosis in oligodendrogliomas.
    Neuropathol Appl Neurobiol. 2000 Dec;26(6):504-12 PMID: 11123716
  2. Tissue microarray profiling of cancer specimens and cell lines: opportunities and limitations.
    Lab Invest. 2001 Oct;81(10):1331-8 PMID: 11598146
  3. Delineation of prognostic biomarkers in prostate cancer.
    Nature. 2001 Aug 23;412(6849):822-6 PMID: 11518967
  4. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma.
    Am J Pathol. 1999 Apr;154(4):981-6 PMID: 10233835
  5. Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms.
    Int J Cancer. 1994 Nov 15;59(4):520-9 PMID: 7525492
  6. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.
    Nature. 1992 Oct 29;359(6398):845-8 PMID: 1279432
  7. The application of tissue microarrays to cancer research.
    Pathology. 2001 May;33(2):125-9 PMID: 11358042
  8. Validation of tissue microarray technology in breast carcinoma.
    Lab Invest. 2000 Dec;80(12):1943-9 PMID: 11140706
  9. Multitumor "sausage" blocks in immunohistochemistry. Simplified method of preparation, practical uses, and roles in quality assurance.
    Am J Clin Pathol. 1991 Aug;96(2):228-32 PMID: 1862778
  10. Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas/leukemias : combination analysis with cDNA expression array and tissue microarray.
    Am J Pathol. 2001 Oct;159(4):1495-505 PMID: 11583976
  11. Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression.
    Hum Pathol. 2000 Apr;31(4):406-14 PMID: 10821485
  12. Tissue microarray assessment of prostate cancer tumor proliferation in African- American and white men.
    J Natl Cancer Inst. 2000 Jun 7;92(11):937-9 PMID: 10841830
  13. Tissue microarrays for high-throughput molecular profiling of tumor specimens.
    Nat Med. 1998 Jul;4(7):844-7 PMID: 9662379
  14. Tissue microarray technology for high-throughput molecular profiling of cancer.
    Hum Mol Genet. 2001 Apr;10(7):657-62 PMID: 11257096
  15. Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays.
    J Natl Cancer Inst. 1999 Oct 20;91(20):1758-64 PMID: 10528027
  16. Molecular mechanisms of developmental and tumor angiogenesis.
    Brain Pathol. 1994 Jul;4(3):207-18 PMID: 7524960
  17. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors.
    Am J Pathol. 2001 Apr;158(4):1245-51 PMID: 11290542
  18. Amplification of tissue by construction of tissue microarrays.
    Exp Mol Pathol. 2001 Jun;70(3):255-64 PMID: 11418004
  19. Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis.
    J Natl Cancer Inst. 2000 Aug 2;92(15):1252-9 PMID: 10922410
  20. Relational database structure to manage high-density tissue microarray data and images for pathology studies focusing on clinical outcome: the prostate specialized program of research excellence model.
    Am J Pathol. 2001 Sep;159(3):837-43 PMID: 11549576
  21. Tissue microarrays for gene amplification surveys in many different tumor types.
    Clin Cancer Res. 1999 Aug;5(8):1966-75 PMID: 10473073
  22. Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling.
    Cancer Res. 1999 Sep 1;59(17):4228-32 PMID: 10485462
  23. Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques.
    Cancer Res. 2000 Dec 1;60(23):6617-22 PMID: 11118044
  24. High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer.
    Am J Pathol. 2000 Sep;157(3):787-94 PMID: 10980118
  25. Web-based tissue microarray image data analysis: initial validation testing through prostate cancer Gleason grading.
    Hum Pathol. 2001 Apr;32(4):417-27 PMID: 11331959
  26. High-throughput molecular profiling of high-grade astrocytomas: the utility of fluorescence in situ hybridization on tissue microarrays (TMA-FISH).
    J Neuropathol Exp Neurol. 2002 Dec;61(12):1078-84 PMID: 12484570
  27. Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays.
    Cancer Res. 1999 Feb 15;59(4):803-6 PMID: 10029066
  28. The multitumor (sausage) tissue block: novel method for immunohistochemical antibody testing.
    Lab Invest. 1986 Aug;55(2):244-8 PMID: 3525985
  29. Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade.
    J Pathol. 2001 Jul;194(3):349-57 PMID: 11439368
Article Info
Journal
Brain pathology (Zurich, Switzerland)
Abbr.
Brain Pathol
ISSN
1015-6305
Published
2002-01-00
Pages
95-107
Language
English
Region
Switzerland
NLM ID
9216781
PMCID
PMC8095954
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com